OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

p53 modifications: exquisite decorations of the powerful guardian
Yanqing Liu, Omid Tavana, Wei Gu
Journal of Molecular Cell Biology (2019) Vol. 11, Iss. 7, pp. 564-577
Open Access | Times Cited: 335

Showing 1-25 of 335 citing articles:

p53 in ferroptosis regulation: the new weapon for the old guardian
Yanqing Liu, Wei Gu
Cell Death and Differentiation (2022) Vol. 29, Iss. 5, pp. 895-910
Open Access | Times Cited: 346

Gain-of-function mutant p53 in cancer progression and therapy
Cen Zhang, Juan Liu, Dandan Xu, et al.
Journal of Molecular Cell Biology (2020) Vol. 12, Iss. 9, pp. 674-687
Open Access | Times Cited: 250

iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4
Delin Chen, Bo Chu, Xin Yang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 241

The Regulation of Ferroptosis by Tumor Suppressor p53 and its Pathway
Juan Liu, Cen Zhang, Jianming Wang, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8387-8387
Open Access | Times Cited: 196

The complexity of p53-mediated metabolic regulation in tumor suppression
Yanqing Liu, Wei Gu
Seminars in Cancer Biology (2021) Vol. 85, pp. 4-32
Open Access | Times Cited: 179

The transcription factor activity gradient (TAG) model: contemplating a contact-independent mechanism for enhancer–promoter communication
Jonathan P. Karr, John J. Ferrie, Robert Tjian, et al.
Genes & Development (2021) Vol. 36, Iss. 1-2, pp. 7-16
Open Access | Times Cited: 118

Understanding the complexity of p53 in a new era of tumor suppression
Yanqing Liu, Zhenyi Su, Omid Tavana, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 946-967
Open Access | Times Cited: 102

Protein acylation: mechanisms, biological functions and therapeutic targets
Shuang Shang, Jing Liu, Fang Hua
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 95

p53 at the crossroad of DNA replication and ribosome biogenesis stress pathways
Mikael S. Lindström, Jiří Bártek, Apolinar Maya‐Mendoza
Cell Death and Differentiation (2022) Vol. 29, Iss. 5, pp. 972-982
Open Access | Times Cited: 89

Therapeutics Targeting p53-MDM2 Interaction to Induce Cancer Cell Death
Nayeong Koo, Arun Sharma, Satya Narayan
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5005-5005
Open Access | Times Cited: 80

Protein post-translational modifications in the regulation of cancer hallmarks
Haiying Wang, Liqian Yang, Minghui Liu, et al.
Cancer Gene Therapy (2022) Vol. 30, Iss. 4, pp. 529-547
Closed Access | Times Cited: 79

Post-Translational Modification of GPX4 is a Promising Target for Treating Ferroptosis-Related Diseases
Can Cui, Fei Yang, Qian Li
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 78

Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?
Annabella Thomas, Gemma L. Kelly, Andreas Strasser
Cell Death and Differentiation (2022) Vol. 29, Iss. 5, pp. 961-971
Open Access | Times Cited: 77

The ARTS of p53-dependent mitochondrial apoptosis
Qian Hao, Jiaxiang Chen, Hua Lu, et al.
Journal of Molecular Cell Biology (2022) Vol. 14, Iss. 10
Open Access | Times Cited: 73

Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy
Bin Song, Ping Yang, Shuyu Zhang
Cancer Communications (2024) Vol. 44, Iss. 3, pp. 297-360
Open Access | Times Cited: 29

Type 2 diabetic mellitus related osteoporosis: focusing on ferroptosis
Yili Chen, Wen Zhao, An Bin Hu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 17

Reactive Oxygen Species Induced p53 Activation: DNA Damage, Redox Signaling, or Both?
Tao Shi, Tobias B. Dansen
Antioxidants and Redox Signaling (2020) Vol. 33, Iss. 12, pp. 839-859
Closed Access | Times Cited: 112

Current developments of targeting the p53 signaling pathway for cancer treatment
Jing Huang
Pharmacology & Therapeutics (2020) Vol. 220, pp. 107720-107720
Open Access | Times Cited: 112

p53 Deacetylation Alleviates Sepsis-Induced Acute Kidney Injury by Promoting Autophagy
Maomao Sun, Jiaxin Li, Liangfeng Mao, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 101

Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?
Simin Qi, Gang Cheng, Xiangdong Cheng, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 96

Human papillomavirus E6 and E7: What remains?
Arushi Vats, Óscar Trejo-Cerro, Miranda Thomas, et al.
Tumour Virus Research (2021) Vol. 11, pp. 200213-200213
Open Access | Times Cited: 96

Hallmarks and detection techniques of cellular senescence and cellular ageing in immune cells
Dingxi Zhou, Mariana Borsa, Anna Katharina Simon
Aging Cell (2021) Vol. 20, Iss. 2
Open Access | Times Cited: 89

The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer
Cen Zhang, Juan Liu, Jianming Wang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 76

Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
Paola Monti, Paola Menichini, Andrea Speciale, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 71

Page 1 - Next Page

Scroll to top